C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2002
12/19/2002	US20020193298 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
12/19/2002	US20020193297 Recombinant human alpha-fetoprotein as an immunosuppressive agent
12/19/2002	US20020193296 Vaccines; therapy; prophylaxis
12/19/2002	US20020193295 Immunogenic peptides and uses thereof
12/19/2002	US20020193294 For inhibiting functions such as cell adhesion and the formation of tissue permeability barriers
12/19/2002	US20020193293 Low oxygen affinity mutant hemoglobins
12/19/2002	US20020193292 For therapy of diabetes
12/19/2002	US20020193287 Mixing subunit complex is cardiac troponin IC (cTnIC) solution with an active polymer to form a stabilized cTnIC-polymer conjugate
12/19/2002	US20020193284 Methods for identifying modulators of NF-KB activity
12/19/2002	US20020192826 Recombinant AAV vector-based transduction system and use of same
12/19/2002	US20020192824 Viral vectors having chimeric envelope proteins containing the IgG-binding domain of protein A
12/19/2002	US20020192822 Herpes simplex virus ICP4 is an inhibitor of apoptosis
12/19/2002	US20020192821 Increased functional activity and/or expression of ABC transporters protects against the loss of dopamine neurons associated with Parkinson's disease
12/19/2002	US20020192820 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/19/2002	US20020192814 Colloidal metal compositions and methods
12/19/2002	US20020192800 Nucleotide sequences coding polypeptide for use in the prevention, diagnosis and treatment of thrombosis, emphysema and liver disorders
12/19/2002	US20020192799 Polypeptides for use in the treatment and prevention of infections
12/19/2002	US20020192798 Zcys9: a member of the cystatin superfamily
12/19/2002	US20020192797 Process for the preparation of protease inhibitor using novel alkalothermophilic bacillus sp
12/19/2002	US20020192796 Anti-sigma28 factors in Helicobacter pylori, Campylobacter jejuni and Pseudomonas aeruginosa and applications thereof
12/19/2002	US20020192793 Isolation of the biosynthesis genes for pseudo-oligosaccharides from Streptomyces glaucescens GLA.O, and their use
12/19/2002	US20020192792 Laccase mutants
12/19/2002	US20020192789 Novel enterokinase cleavage sequences
12/19/2002	US20020192785 For use in therapeutics, diagnostics, and as research tools
12/19/2002	US20020192781 Desaturase antigen of mycobacterium tuberculosis
12/19/2002	US20020192780 Novel anti-inflammatory peptides
12/19/2002	US20020192779 Nucleotide sequences coding polypeptide for use in the treatment of cancer
12/19/2002	US20020192778 Nucleotide sequences coding polypeptide for use in the treatment of cancer
12/19/2002	US20020192777 Polypeptide for use in the treatment of inflammatory defects
12/19/2002	US20020192776 Nucleotide sequences coding polypeptide for use as insecticide
12/19/2002	US20020192763 Compositions and methods for the therapy and diagnosis of prostate cancer
12/19/2002	US20020192762 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
12/19/2002	US20020192761 Isolated human transporter proteins, nucleic acid moleculed encoding human transporter proteins, and uses thereof
12/19/2002	US20020192760 Nucleotide sequences coding membrane protein for use the diagnosis and treatment of asthma, parkinson's, heart defects, hypotension, urogenital disorders
12/19/2002	US20020192758 C3b/C4b complement receptor-like molecules and uses thereof
12/19/2002	US20020192757 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
12/19/2002	US20020192753 Method of making proteins in transformed yeast cells
12/19/2002	US20020192752 Compositions and methods for the treatment of immune related diseases
12/19/2002	US20020192751 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of sepsis and inflammatory defects
12/19/2002	US20020192750 Polypeptide for use in the treatment and diagnosis of solid tumors, rheumatoid arthritis, vision defects and atherosclerosis
12/19/2002	US20020192749 Human polynucleotides, polypeptides, and antibodies
12/19/2002	US20020192748 Novel polynucleotides and polypeptides encoded thereby
12/19/2002	US20020192745 For diagnosing degenerative disorders characterized in inappropriate cell proliferation or inappropriate cell death; formonitoring the progress of such degenerative disorders
12/19/2002	US20020192744 Useful in the nutrition of patients suffering from phenylketonuria
12/19/2002	US20020192737 Detecting modulators of oxidoreductases; obtain sample, incubate with modulator, detect signal, monitor adjustment in enzyme activity
12/19/2002	US20020192729 Apoptosis protein for use in the diagnosis and treatment of cell proliferative disorders
12/19/2002	US20020192724 Methods and compositions for modulating heterotypic E-cadherin interactions with T lymphocytes
12/19/2002	US20020192723 Protein for use in the diagnosis and treatment of autoimmune disease
12/19/2002	US20020192710 Diagnostics, assay methods and amelioration of muscular dystrophy symptoms
12/19/2002	US20020192709 Detection of modulators of receptor binding activity; obtain sample containing receptor, incubate with modulator, monitor adjustment of binding activity of receptor
12/19/2002	US20020192706 Nucleotide sequences coding polypeptides for use treatment of cell proliferation disorders
12/19/2002	US20020192704 Protein for use in the treatment of diabebtes, gastrointestinal disorders and kidney defects
12/19/2002	US20020192699 Genes and gene expression products that are differentially regulated in prostate cancer
12/19/2002	US20020192693 Apparatus for polymer synthesis
12/19/2002	US20020192689 Detection of preferential nucleotidse sequences; obtain sample, incubate with probe, detect signal, recover nucleotide sequences
12/19/2002	US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002	US20020192678 Genes expressed in senescence
12/19/2002	US20020192675 Detection of nucleotide sequences coding polypeptide associated with controlling gene expression; obtain cells, transform with nucleotide sequences coding regulatory polypeptides, monitor adjustment in preferential gene
12/19/2002	US20020192672 Cell culture for use in the detection of ehrlichia infections
12/19/2002	US20020192668 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192666 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer
12/19/2002	US20020192665 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
12/19/2002	US20020192660 Reducing effect of regulatory sequences on transcription; obtain nucleotide sequences, detect regulatory sequences, mutate, transfect into cell, culture, monitor adjustment in transcription control
12/19/2002	US20020192659 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002	US20020192647 Diagnostic method
12/19/2002	US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002	US20020192640 Purified active HCV NS2/3 protease
12/19/2002	US20020192639 HCV antigen/antibody combination assay
12/19/2002	US20020192634 EG-VEGF nucleic acids and polypeptides and methods of use
12/19/2002	US20020192633 Non-lethal method for extracting crude hemocyanin from gastropod molluscs
12/19/2002	US20020192315 Process for preparing cooagulants for water treatment
12/19/2002	US20020192237 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
12/19/2002	US20020192236 Culture product; purification of cytotoxin; gastrointestinal disorders; antiulcer agents
12/19/2002	US20020192233 Tuberculosis vaccine; genetic engineering
12/19/2002	US20020192232 Methods and compositions for impairing multiplication of HIV-1
12/19/2002	US20020192230 Therapeutic formulations using heat shock/stress protein-peptide complexes
12/19/2002	US20020192229 MHC class I associated peptides for prevention and treatment of tuberculosis
12/19/2002	US20020192228 Protein markers for lung cancer and use thereof
12/19/2002	US20020192226 Production of a parvovirus vaccine in plants as viral coat protein fusions
12/19/2002	US20020192223 Novel antibody conjugates reactive with human carcinomas
12/19/2002	US20020192220 Compositions and methods relating to colon specific genes and proteins
12/19/2002	US20020192219 Morphogenic proteins
12/19/2002	US20020192216 Therapeutic use
12/19/2002	US20020192214 Eosinophil eotaxin receptor
12/19/2002	US20020192213 Monoclonal antibodies specific to VEGF receptors and uses thereof
12/19/2002	US20020192208 Novel osteopontin derived chemotactic peptides and methods of use
12/19/2002	US20020192205 Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococci
12/19/2002	US20020192199 Composition and methods for enhanced tumor cell immunity in vivo
12/19/2002	US20020192193 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192192 Antigen presenting cells, a process for preparing the same and their use as cellular vaccines
12/19/2002	US20020192188 Use of recombinant adeno-associated virus vector (rAAV) for the prevention of smooth muscle cell proliferation in a vascular graft
12/19/2002	US20020192187 Gene transfer with adenoviruses having modified fiber proteins
12/19/2002	US20020192185 Recombinant protein production in bovine adenovirus expression vector system
12/19/2002	US20020192183 Interferon gamma polypeptide variants
12/19/2002	US20020192160 Novel human tumor suppressor gene
12/19/2002	DE10129010A1 Producing a transgenic plant or plant cell expressing a transgene under control of native transcription and translation elements already present in the genome is useful to give stable expression of transgenes
12/19/2002	DE10128661A1 Nucleic acid molecule comprising one or more genes from Stigmatella species
12/19/2002	CA2488850A1 Sustained release n-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating cancer
12/19/2002	CA2465884A1 Transgenic plants synthesising high amylose starch
12/19/2002	CA2450669A1 Anti-apoptosis genes and methods of use thereof

1 ... 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 ... 2916